Get started
Work

Abstract S4-05: Impact of intrinsic subtype by PAM50 and other gene signatures on pathologic complete response (pCR) rates in triple-negative breast cancer (TNBC) after neoadjuvant chemotherapy (NACT) +/- carboplatin (Cb) or bevacizumab (Bev): CALGB 40603/150709 (Allianc

Year: 2015
Type: conference-abstract
DOI: 10.1158/1538-7445.sabcs14-s4-05
Authors: William M Sikov, William T Barry, Katherine A Hoadley, Brandelyn N Pitcher, Baljit Singh, Sara M Tolaney, Charles S Kuzma, Timothy J Pluard, George Somlo, Elisa R Port, Mehra Golshan, Donald A Berry, Olwen M Hahn, Lisa A Carey, Charles M Perou, Clifford A Hudis, Eric P Winer
Institutions: Brown University, Dana-Farber Cancer Institute, UNC Lineberger Comprehensive Cancer Center, NYU Langone Health, New York University, Washington University in St. Louis, City Of Hope National Medical Center, City of Hope, Mount Sinai Medical Center, The University of Texas MD Anderson Cancer Center, University of Chicago Medical Center, Memorial Sloan Kettering Cancer Center
Language: English
Subfield: Cancer Research
Open Access status: closed
OpenAlex ID: W1510425392
Cites:
Cited by: 18
Related to: 10